Tech stocks tumbled Thursday as investors sold off following Nvidia's blockbuster earnings results, with the company dropping 4.5% and dragging the semiconductor sector lower. The VIX volatility index rallied over 10%, while the Magnificent 7 stocks collectively lost roughly $400 billion in market capitalization. Energy outperformed with a 0.8% gain, while technology led declines with a 2% drop. Michael Burry warned that Nvidia's purchase commitments resemble dot-com bubble levels.

Universal Health Services, Inc. (NYSE: UHS) announced that its Board of Directors approved a cash dividend of $0.20 per share payable on March 16, 2026 to shareholders of record as of March 2, 2026.

The U.S. mental health treatment market is valued at $118 billion and is projected to grow significantly through 2030, driven by increased awareness, technology integration, and rising mental illness prevalence affecting 61 million Americans. The sector faces challenges including a shortage of mental health professionals and access gaps, while teletherapy and mental health apps have created a $2 billion market segment. Major players include facility operators like Acadia Healthcare and Universal Health Services, alongside digital platforms such as Lyra Health, Spring Health, Headspace, Calm, Talkspace, and BetterHelp.

The article highlights three healthcare stocks trading at attractive valuations: DaVita, Merck, and Universal Health Services, which offer potential investment opportunities despite current market challenges.

Universal Health Services reported strong Q2 2025 financial results, with revenue of $4.28 billion and EPS of $5.35, exceeding analyst estimates. The company benefited from higher Medicaid reimbursements and raised its full-year guidance, though facing potential regulatory challenges.

Universal Health Realty Income Trust reported a slight decline in net income and funds from operations in Q2 2025, with minor revenue growth and a cautious dividend increase amid challenging healthcare operating environment.

The article explores three high-dividend healthcare REITs that have demonstrated resilience during the COVID-19 pandemic, focusing on senior housing and medical office properties with attractive dividend yields ranging from 6.4% to 7.1%.

Universal Health Realty Income Trust offers a high 7.4% dividend yield, with a 40-year history of annual dividend increases. While attractive for income investors, it has slower dividend growth and potential conflicts of interest due to external management.

The article compares Johnson & Johnson's dividend performance with Universal Health Realty Income Trust, highlighting the latter's significantly higher dividend yield of 7.4% versus J&J's 3.4%, and suggesting it might be more attractive for income-focused investors.

Universal Health Services, Inc. announced that its Board of Directors voted to pay a cash dividend of $0.20 per share on June 16, 2025, to shareholders of record as of June 02, 2025.

Universal Health Services, Inc. announced that its Board of Directors voted to pay a cash dividend of $0.20 per share on March 17, 2025 to shareholders of record as of March 03, 2025.

The White House has ordered a temporary freeze on all federal grants and loans, putting $3 trillion in funding under scrutiny and threatening industries like clean energy, defense, and healthcare.